ANI PHARMACEUTICALS INC
ANIPNASDAQ🏆 #2058 by market capEarnings Nov 5 · PreUS Equity
$73.13▲ $1.43 (+1.99%)
Market closed · at closeTrack ANIP
Get earnings, price moves & breaking news on Telegram
24h▲ 2.0%
7d▲ 0.8%
14d▲ 1.3%
30d▲ 0.5%
ytd▼ 7.4%
1y▼ 20.5%
🏦Market Cap
$1.68B
Small Cap
📈Revenue Growth (YoY)
30.9%
High Growth
📊Gross Margin
60.4%
High
💵FCF Margin
17.7%
Healthy
⚖️P/S Ratio
1.7x
Cheap
Otter Score
80
Strong
Trading Snapshot
- Day Range
- $72.35 – $73.40
- 52-Week Range
- $69.58 – $96.57
- Volume (shares)
- 11,693
- Avg Volume (shares)
- —
- Shares Outstanding
- 23.0M
- Next Earnings
- 2026-11-05
Fundamentals Snapshot
- Annual Revenue
- $883M
- Last Q Revenue
- $266M
- P/E Ratio
- 15.1
- P/S Ratio
- 1.7x
- EPS (TTM)
- $5.00
- Dividend Yield
- 0.02%
- Dilution (1yr)
- +9.2%
ANI PHARMACEUTICALS INC
ANIPFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$883M▲ +43.8% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
51.0%▼ −13.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$81M▲ +13809.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$151M▲ +220.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
21.2M▲ +9.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$40M▲ +$440M YoY
StockOtter · stockotter.spaceAbout ANI PHARMACEUTICALS INC
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Strong
80/100
Analyst Ratings
ⓘConsensus
Buy
15 analysts
Strong Buy5
Buy7
Hold3
Sell0
Strong Sell0
Ratings as of Oct 2026
Latest News & Updates
News unavailable.